Novel use of carboplatin, etoposide and durvalumab as neoadjuvant therapy in treatment of small cell bladder cancer. Gonzalez V, Linton E, Boyce T, Dahmoush L, et al. Urol Case Rep 2025;62:103165.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gonzalez V, Linton E, Boyce T, Dahmoush L, et al. Novel use of carboplatin, etoposide and durvalumab as neoadjuvant therapy in treatment of small cell bladder cancer. Urol Case Rep 2025;62:103165.
PMID: 40894098